-
Hanmi Science Consortium Drives Ambitious Project for Worldwide Vaccine Equity
prnasia
October 29, 2021
Hanmi Science doesn't just want the world to know they are committed to vaccine equity, they want to prove it. Mr. Lim, CEO of Hanmi Science, echoes the concerns of Mr. Bill Gates, co-founder of the Bill & Melinda Gates Foundation.
-
Q&A: COVID-19 vaccine shots for children
NMPA
October 29, 2021
Giving children COVID-19 vaccine shots is an important part of building up immunity barrier for the entire population, as well as an important measure to block the spread of the COVID-19 virus.
-
Review of Covaxin underway, expect a recommendation within 24 hours: WHO
ExpressPharma
October 28, 2021
A technical advisery group of the World Health Organization (WHO) was yesterday reviewing data on Covaxin for the Emergency Use Listing (EUL) of India’s indigenously-made vaccine and if it is satisfied...
-
CyanVac eyes fundraise for parainfluenza-vectored Covid-19 vaccine after December data
Pharmaceutical-Technology
October 28, 2021
CyanVac expects its Phase I parainfluenza virus-vectored Covid-19 vaccine trial to have early data in December, which could be the impetus for a $30m fundraise.
-
Emergency Physicians: We Must Address Vaccine Hesitancy, Correct Misinformation to End Pandemic
October 25, 2021
Widespread misinformation about COVID-19 vaccines and treatments fuels vaccine hesitancy and stands in the way of efforts to end the pandemic, according to doctors with the American College of Emergency Physicians (ACEP).
-
Red Ginseng's possible COVID-19 Vaccine Adjuvant Effect gave out from Korean Ginseng Research Institute
prnasia
October 21, 2021
Korean Ginseng Research Institute, recently published research results on 'the vaccine adjuvant effect of red ginseng' and 'respiratory damage prevention effect'.
-
Novavax defends COVID-19 vaccine manufacturing processes after claims of quality issues
CPhIonline
October 21, 2021
US biotech Novavax has defended its manufacturing processes after a recent report which claimed the company was struggling to meet US Food and Drug Administration quality standards in the production of its COVID-19 vaccine.
-
Phase II Data Of Medigen COVID-19 Vaccine, Reviewed And Published In The Lancet Respiratory Medicine
prnasia
October 18, 2021
The Lancet Respiratory Medicine, one of the world's best-known peer-reviewed medical journals has published Medigen Vaccine Biologics (MVC) data from its MVC-COV1901 vaccine phase 2 clinical trial...
-
Cellumed and ARTES Sign Development and License Agreement
B3Cnewswire
October 15, 2021
Today, Cellumed Co. Ltd., listed stock market company and Germany based ARTES Biotechnology GmbH announce the execution of a Development and License Agreement aiming at the generation of microbial production cell lines...
-
BD Completes Study Investigating Performance of Glass Prefillable Syringes (PFS) in Deep Cold Storage
B3Cnewswire
September 28, 2021
BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, completed a preliminary study investigating the impact of deep cold storage (-20°C and -40°C) on glass PFS.
ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
Widespread misinformation about COVID-19 vaccines and treatments fuels vaccine hesitancy and stands in the way of efforts to end the pandemic, according to doctors with the American College of Emergency Physicians (ACEP).
Pharma Sources Insight January 2025
